• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肝病模型(MELD)时代:现在是时候在失代偿期肝硬化患者中取代原始的Child-Pugh评分了吗?

MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.

作者信息

Shaikh Samiullah, Ghani Hanif, Memon Sadik, Baloch Ghulam Hussain, Jaffery Mukhtiar, Shaikh Khalid

机构信息

Department of Medicine, Liaquat University of Medical and Health Sciences, Hyderabad, Pakistan.

出版信息

J Coll Physicians Surg Pak. 2010 Jul;20(7):432-5.

PMID:20642940
Abstract

OBJECTIVE

To compare the predictive value of MELD (Model of end stage liver disease) and Child-Pugh (CP) scores in patients with decompensated cirrhosis of liver.

STUDY DESIGN

Descriptive study.

PLACE AND DURATION OF STUDY

Medical Department, Liaquat University of Medical and Health Sciences, Jamshoro/ Hyderabad, from August 2006 to October 2007.

METHODOLOGY

This study included 110 consecutive patients with decompensated cirrhosis of liver diagnosed either clinically or radiologically were followed-up during hospital stay. Studied variables included demographic data, cirrhosis related complications and investigations. Patients were classified according to original CP classification into A, B and C. MELD score was estimated from serum bilirubin, serum creatinine and INR (International normalized ratio) of the patients. Duration of hospitalization and in-hospital mortality were made as the end points of the study. T-test and Chi-square test were done for continuous and categorical data. Original CP and MELD score were compared by the ROC curve. 0.05 was kept as the level of significance.

RESULTS

There were 110 patients with decompensated cirrhosis of liver. Mean age was 46.76+12.93 years. There were 72 (65%) male and 38 (35%) females patients. Hepatitis C was the most prevalent cause of cirrhosis of liver present in 60/110 (60%) cases. Ascites was present in 93/110 (83%) patients. The mean MELD scores were 2.23+0.712 (95% CI 2.09 - 2.36) and for CTP 2.52+0.586 (95%; CI 2.41-2.63). The outcome of the patients were 12 deaths (11%); 54 (49%) remained hospitalized for up to 14 days and 44 (40%) for > 14 days. The majority of deaths and prolong hospitalization were found in patients with MELD score > 15 as well as with Child-Pugh grade C. The c-statistic was 0.726 (p=0.001) for CP score, and 0.642 for MELD score (p=0.021).

CONCLUSION

The MELD score was not found to be superior to CTP score for short-term prognostication of patients with cirrhosis in this study.

摘要

目的

比较终末期肝病模型(MELD)和Child-Pugh(CP)评分对失代偿期肝硬化患者的预测价值。

研究设计

描述性研究。

研究地点及时间

2006年8月至2007年10月,在詹姆肖罗/海得拉巴的利亚卡特医科大学医学部。

方法

本研究纳入110例经临床或影像学诊断为失代偿期肝硬化的连续患者,在住院期间进行随访。研究变量包括人口统计学数据、肝硬化相关并发症及检查。患者根据原始CP分级分为A、B、C级。根据患者的血清胆红素、血清肌酐和国际标准化比值(INR)估算MELD评分。将住院时间和院内死亡率作为研究终点。对连续数据和分类数据分别进行t检验和卡方检验。通过ROC曲线比较原始CP评分和MELD评分。显著性水平设定为0.05。

结果

110例失代偿期肝硬化患者。平均年龄为46.76±12.93岁。男性72例(65%),女性38例(35%)。丙型肝炎是肝硬化最常见的病因,占60/110(60%)例。93/110(83%)患者出现腹水。MELD评分均值为2.23±0.712(95%CI 2.09 - 2.36),CTP评分为2.52±0.586(95%;CI 2.41 - 2.63)。患者结局为12例死亡(11%);54例(49%)住院时间长达14天,44例(40%)住院时间>14天。大多数死亡和延长住院时间的情况见于MELD评分>15以及Child-Pugh C级的患者。CP评分的c统计量为0.726(p = 0.001),MELD评分为0.642(p = 0.021)。

结论

在本研究中,MELD评分在肝硬化患者短期预后评估方面并不优于CTP评分。

相似文献

1
MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver.终末期肝病模型(MELD)时代:现在是时候在失代偿期肝硬化患者中取代原始的Child-Pugh评分了吗?
J Coll Physicians Surg Pak. 2010 Jul;20(7):432-5.
2
Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.与原始Child Pugh评分相比,评估肌酐修正的Child Pugh评分对失代偿期肝硬化患者短期预后的预测价值。
J Ayub Med Coll Abbottabad. 2009 Apr-Jun;21(2):64-7.
3
Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.终末期肝病模型(MELD)作为慢性肝病患者短期预后指标的适用性:一项印度的经验。
J Gastroenterol Hepatol. 2007 Aug;22(8):1232-5. doi: 10.1111/j.1440-1746.2007.04903.x.
4
[New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].[肝硬化和肝细胞癌严重程度结局的新评分系统:关于Child-Turcotte-Pugh评分和终末期肝病模型(MELD)评分的当前问题]
Taehan Kan Hakhoe Chi. 2003 Sep;9(3):167-79.
5
Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.终末期肝病模型(MELD)评分作为肝硬化感染患者有用的预后标志物。
J Coll Physicians Surg Pak. 2009 Nov;19(11):694-8.
6
Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?纳入血清肌酐值能否改善Child-Turcotte-Pugh评分,并在肝硬化患者的短期预后评估中对终末期肝病模型评分的预后价值提出挑战?
Liver Int. 2004 Oct;24(5):465-70. doi: 10.1111/j.1478-3231.2004.0949.x.
7
Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis.血清肌酐浓度升高作为失代偿期肝硬化短期预后预测指标的临床价值
Scand J Gastroenterol. 2004 Nov;39(11):1149-53. doi: 10.1080/00365520410008024.
8
[The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis].[肝硬化患者基于CTP评分和MELD评分的死亡率分析]
Taehan Kan Hakhoe Chi. 2003 Jun;9(2):98-106.
9
Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.终末期肝病评分与血清钠比值指数模型作为肝硬化患者预后预测指标的验证
J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.
10
Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.终末期肝病模型对失代偿期慢性乙型肝炎患者死亡率的预测评估
Am J Gastroenterol. 2006 Jul;101(7):1516-23. doi: 10.1111/j.1572-0241.2006.00659.x.

引用本文的文献

1
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis.肝功能障碍与经皮冠状动脉介入治疗后结局的关系:系统评价和荟萃分析。
BMC Cardiovasc Disord. 2024 Oct 21;24(1):580. doi: 10.1186/s12872-024-04252-9.
2
Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy.失代偿期肝硬化患者死亡率预测评分系统:检验准确性的Meta分析
World J Clin Cases. 2018 Dec 6;6(15):995-1006. doi: 10.12998/wjcc.v6.i15.995.
3
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.
用于评估肝硬化预后的Child-Pugh评分与终末期肝病模型(MELD)评分:观察性研究的系统评价和荟萃分析
Medicine (Baltimore). 2016 Feb;95(8):e2877. doi: 10.1097/MD.0000000000002877.
4
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.预测广泛肝病患者的死亡率——对终末期肝病模型(MELD)、Child-Turcotte-Pugh(CTP)评分以及肌酐修正CTP评分的评估
J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.
5
MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis.肝脏磁共振弛豫时间测定:肝硬化患者 T1 弛豫时间显著升高。
Eur Radiol. 2012 Jun;22(6):1224-32. doi: 10.1007/s00330-012-2378-5. Epub 2012 Feb 3.